Guidelines     MGP Ltd



Forthcoming guidance
 
Published guidance
 
Select guidance type:
Select Clinical speciality:

Date: from to

Search



Title Type Clinical speciality   Published date   Review Date
Pentosan polysulfate sodium for treating bladder pain syndrome NICE Technology Appraisal Urology Nov 2019 -
Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer NICE Technology Appraisal Cancer Nov 2019 -
ribociclib (Kisqali) SMC advice Cancer Nov 2019 -
pentosan polysulfate sodium (Elmiron) SMC advice Urology Nov 2019 -
trientine tetrahydrochloride (Cuprior) SMC advice Genetic conditions Nov 2019 -
imiquimod (Zyclara) SMC advice Skin and wound care Nov 2019 -
clostridium botulinum neurotoxin type A (Xeomin) SMC advice Neurology Nov 2019 -
glecaprevir/pibrentasvir (Maviret) SMC advice Infection Nov 2019 -
lenvatinib (Kisplyx) SMC advice Cancer Nov 2019 -
atezolizumab (Tecentriq) SMC advice Cancer Nov 2019 -
Cannabis-based medicinal products NICE Clinical Guideline Neurology Nov 2019 -
Fever in under 5s: assessment and initial management NICE Clinical Guideline Infection Nov 2019 -
Multiple sclerosis in adults: management NICE Clinical Guideline Neurology Nov 2019 -
Ibrutinib with rituximab for treating Waldenstrom’s macroglobulinaemia (terminated appraisal) NICE Technology Appraisal Cancer Oct 2019 -
Ramucirumab for treating unresectable hepatocellular carcinoma after sorafenib (terminated appraisal) NICE Technology Appraisal Cancer Oct 2019 -
zanamivir (Dectova®) All Wales Medicines Strategy Group appraisal Infection Oct 2019 -
glecaprevir/pibrentasvir (Maviret®) All Wales Medicines Strategy Group appraisal Infection Oct 2019 -
Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease NICE Technology Appraisal Cardiovascular Oct 2019 -
Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management NICE Clinical Guideline Gastrointestinal Oct 2019 -
End of life care: service delivery NICE Clinical Guideline Care of the elderly Oct 2019 -
Diabetic foot problems: prevention and management NICE Clinical Guideline Diabetes Oct 2019 -
Lanadelumab for preventing recurrent attacks of hereditary angioedema NICE Technology Appraisal Genetic conditions Oct 2019 -
Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea NICE Technology Appraisal Neurology Oct 2019 -
enzalutamide (Xtandi) SMC advice Cancer Oct 2019 -
pertuzumab (Perjeta) SMC advice Cancer Oct 2019 -
risankizumab (Skyrizi) SMC advice Skin and wound care Oct 2019 -
triptorelin acetate (Decapeptyl) SMC advice Cancer Oct 2019 -
pembrolizumab (Keytruda) SMC advice Cancer Oct 2019 -
axicabtagene ciloleucel (Yescarta) SMC advice Cancer Oct 2019 -
Idelalisib for treating refractory follicular lymphoma NICE Technology Appraisal Cancer Oct 2019 -
Cellulitis and erysipelas: antimicrobial prescribing NICE Clinical Guideline Skin and wound care Sep 2019 -
Bezlotoxumab for preventing recurrent Clostridium difficile infection (terminated appraisal) NICE Technology Appraisal Infection Sep 2019 -
Pomalidomide with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal) NICE Technology Appraisal Cancer Sep 2019 -
Lenalidomide with bortezomib and dexamethasone for untreated multiple myeloma (terminated appraisal) NICE Technology Appraisal Cancer Sep 2019 -
Termination of pregnancy NICE Clinical Guideline Women's health Sep 2019 -
buprenorphine (Buvidal®) All Wales Medicines Strategy Group appraisal Pain Sep 2019 -
Pneumonia (hospital-acquired): antimicrobial prescribing NICE Clinical Guideline Respiratory Sep 2019 -
Pneumonia (community-acquired): antimicrobial prescribing NICE Clinical Guideline Respiratory Sep 2019 -
Lung cancer in adults NICE Quality Standard Cancer Sep 2019 -
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer NICE Technology Appraisal Cancer Sep 2019 -